Loading...

Ipsen S.A.

IPSEF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$113.13
$0.00(0.00%)

Ipsen S.A. (IPSEF) Stock Overview

Explore Ipsen S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap9.4B
P/E Ratio22.54
EPS (TTM)$6.26
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$138.77

IPSEF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ipsen S.A. (IPSEF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $138.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.54 and a market capitalization of 9.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
4.00%
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
-5.38%
Year-to-Date (YTD) Change
N/A
1-Year Change
12.44%
3-Year Change
21.36%
5-Year Change
10.22%
All-Time (Max) Change
289.59%

Contact Information

https://www.ipsen.com
33 1 58 33 50 00
65 Quai Georges Gorse, Boulogne-Billancourt, 92100

Company Facts

5,358 Employees
IPO DateSep 21, 2009
CountryFR

Frequently Asked Questions

;